GlassScriptPhysician profile
Liane E Donovan
NPI 1093770687
$12,574.45
in general payments reported to CMS, 2019-2025
42 companies · $3,384 in 2025
The $3,384 reported for 2025 was more than what 90% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $533 · 2020: $600 · 2021: $1,032 · 2022: $1,070 · 2023: $1,302 · 2024: $4,654 · 2025: $3,384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,984 · Travel and Lodging: $3,357.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,983.52 |
| Travel and Lodging | $3,356.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $2,828.04 | 2023-2025 | Evoke, Evoke Scs |
| Boston Scientific Corporation | $2,677.56 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16, General - Pain Management |
| Si-Bone, INC. | $1,386.71 | 2021-2025 | |
| Abbvie INC. | $1,159.78 | 2021-2025 | Qulipta, Botox, Mavyret |
| Medtronic, INC. | $1,010.83 | 2021-2025 | Intellis Adaptivestim, Vanta Adaptivestim, Kyphon Express II Kyphopak Tray |
| Spr Therapeutics, INC | $358.95 | 2024-2025 | Sprint Pns System |
| Grt US Holding, INC. | $338.24 | 2021-2022 | |
| Lundbeck LLC | $264.79 | 2020-2025 | Vyepti |
| Allergan, INC. | $211.70 | 2019-2020 | |
| Abbott Laboratories | $205.23 | 2019-2024 | Proclaim, Eterna |
| Lilly USA, LLC | $194.42 | 2019-2023 | Emgality |
| Forte Bio-Pharma LLC | $177.72 | 2022-2025 | Prolate, Nalocet, Tanlor |
| Pfizer INC. | $149.75 | 2019-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $128.23 | 2022 | |
| Collegium Pharmaceutical, INC. | $127.13 | 2022-2025 | Belbuca, Xtampza |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Liane Donovan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.